What’s New in Artificial Intelligence
-
EU AI Act Brings Real Compliance Implications for Organizations and Audit Teams
The European Union’s Artificial Intelligence Act will reshape AI development and oversight from 2026, affecting both EU-based and external organizations using AI within the region. Companies must classify AI systems by risk, enhance governance, and ensure compliance. Internal audit teams will need to adapt to new requirements and collaborate with IT for effective governance. Read more
-
Meta and NVIDIA Join Forces to Revolutionize AI Infrastructure
Meta Platforms has partnered with NVIDIA to strengthen its AI infrastructure across global data centers. This multiyear agreement involves deploying millions of NVIDIA GPUs and CPUs, enhancing network efficiency and secure AI processing. The collaboration aims to support Meta’s ambitious AI services while promoting improved performance and privacy for its user base. Read more
-
GE HealthCare Partners with Diagnoly for AI-Powered Ultrasound
GE HealthCare has partnered with Diagnoly to integrate the AI-driven Fetoly™ solution into its Voluson™ ultrasound systems, enhancing fetal imaging and examinations. This collaboration aims to improve detection capabilities for fetal abnormalities, streamline workflows, and provide standardized assessments, ultimately supporting better prenatal care. Fetoly is now available in the U.S. and Europe. Read more
-
Bristol Myers Squibb joins Microsoft: AI in Lung Cancer Detection
Bristol Myers Squibb has partnered with Microsoft to enhance early lung cancer detection using AI in clinical radiology. This collaboration aims to implement AI algorithms for X-ray and CT scan analysis, particularly in underserved communities, improving diagnosis and care pathways for non-small cell lung cancer while promoting health equity. Read more
-
Aidoc Gains FDA Approval for Innovative AI Triage Solution
Aidoc has received FDA clearance for the first comprehensive AI triage solution for abdominal CT imaging, enhancing detection and prioritization of critical findings. This innovative system integrates multiple workflows into one, improving efficiency and reducing false alerts. The technology is expected to transform radiology practices and patient outcomes across healthcare settings. Read more
-
NVIDIA, Eli Lilly Launch AI Co-Innovation Lab for Drug Discovery
NVIDIA and Eli Lilly have launched a co-innovation AI lab aimed at transforming drug discovery through the integration of AI and pharmaceutical expertise. This collaboration, announced at the J.P. Morgan Healthcare Conference, signifies a strategic investment of up to $1 billion to overcome research bottlenecks and enhance drug development efficiency. Read more
-
“Wiley Issues Guidelines for Responsible Use of AI in Scholarly Writing”
John Wiley & Sons has introduced guidelines for authors on the responsible use of artificial intelligence (AI) in scholarly writing. Emphasizing transparency, human oversight, and ethical considerations, the guidelines encourage authors to validate AI-generated content and maintain control over their manuscripts, ensuring academic integrity in AI-assisted writing. Read more